Need For A Smarter Regulatory System To Ensure Access To Affordable Biologics: The Biosimilars

Posted on

New Drug Approvals

Kiran Mazumdar Shaw
by
Kiran Mazumdar Shaw, MD, BIOCON
The global pharmaceutical industry is going through a paradigm change as biologics such as monoclonal antibodies and recombinant proteins find greater acceptance for treating a wide range of chronic diseases.
Today biologics make for up half of the top 10 best-selling drugs worldwide.

View original post

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s